Johnson & Johnson plans to invest $1B to expand contact lens production at its U.S. Vision manufacturing and supply chain operations in Jacksonville, Florida by investing in its manufacturing, packaging, and distribution capabilities to better meet growing demand for its products, including the Acuvue brand.
The plant is currently under construction and is expected to be fully operational by 2028. The facility is part of a previous plan to invest $55 billion in its U.S. manufacturing footprint, R&D capacity, and technology across its drug and device segments through 2029. The plan was to build four new manufacturing plants as well as expand existing sites to increase capacity to make medicines and medical devices in the U.S.
The Jacksonville investment will further support the construction of a distribution facility as well as the installation of manufacturing and packaging technologies that will strengthen the company’s supply chain.
